Previous close | 9.02 |
Open | 8.80 |
Bid | 8.65 |
Ask | 12.95 |
Strike | 15.00 |
Expiry date | 2026-01-16 |
Day's range | 8.80 - 11.08 |
Contract range | N/A |
Volume | |
Open interest | 6 |
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the U.S. National Institutes of Health (NIH). Hoau-Yan Wang was a tenured medical professor at a public university’s medical school as well as a former paid science advisor to Cassava Sciences. According to public court documents, Dr. Wang engaged in illegal behavior to defraud the go
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?